These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22560676)

  • 1. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.
    Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP;
    Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
    Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.
    Marquine MJ; Iudicello JE; Morgan EE; Brown GG; Letendre SL; Ellis RJ; Deutsch R; Woods SP; Grant I; Heaton RK;
    Psychiatry Res; 2014 Jan; 215(1):208-16. PubMed ID: 24290100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use.
    Blackstone K; Iudicello JE; Morgan EE; Weber E; Moore DJ; Franklin DR; Ellis RJ; Grant I; Woods SP;
    J Addict Med; 2013; 7(4):255-63. PubMed ID: 23648641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.
    Casaletto KB; Obermeit L; Morgan EE; Weber E; Franklin DR; Grant I; Woods SP;
    Addict Behav; 2015 Jan; 40():45-50. PubMed ID: 25222847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world impact of neurocognitive deficits in acute and early HIV infection.
    Doyle KL; Morgan EE; Morris S; Smith DM; Little S; Iudicello JE; Blackstone K; Moore DJ; Grant I; Letendre SL; Woods SP;
    J Neurovirol; 2013 Dec; 19(6):565-73. PubMed ID: 24277439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailty in Comorbid HIV and Lifetime Methamphetamine Use Disorder: Associations with Neurocognitive and Everyday Functioning.
    Paolillo EW; Saloner R; Montoya JL; Campbell LM; Pasipanodya EC; Iudicello JE; Moore RC; Letendre SL; Jeste DV; Moore DJ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1044-1053. PubMed ID: 31303012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social-cognitive difficulties in former users of methamphetamine.
    Henry JD; Mazur M; Rendell PG
    Br J Clin Psychol; 2009 Sep; 48(Pt 3):323-7. PubMed ID: 19397848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?
    Iudicello JE; Morgan EE; Gongvatana A; Letendre SL; Grant I; Woods SP;
    J Neurovirol; 2014 Feb; 20(1):85-98. PubMed ID: 24470237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
    Dean AC; London ED; Sugar CA; Kitchen CM; Swanson AN; Heinzerling KG; Kalechstein AD; Shoptaw S
    Drug Alcohol Depend; 2009 Nov; 105(1-2):48-55. PubMed ID: 19608354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.
    Cattie JE; Woods SP; Iudicello JE; Posada C; Grant I;
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):331-9. PubMed ID: 23037647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.
    Kalechstein AD; Newton TF; Green M
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):215-20. PubMed ID: 12724464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
    Obermeit LC; Cattie JE; Bolden KA; Marquine MJ; Morgan EE; Franklin DR; Atkinson JH; Grant I; Woods SP;
    Addict Behav; 2013 Dec; 38(12):2874-8. PubMed ID: 24018233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology in methamphetamine-dependent adults 3 years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson RA;
    Drug Alcohol Rev; 2010 Jan; 29(1):12-20. PubMed ID: 20078677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
    Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning.
    Morgan EE; Doyle KL; Minassian A; Henry BL; Perry W; Marcotte TD; Woods SP; Grant I;
    Psychiatry Res; 2014 Dec; 220(1-2):527-34. PubMed ID: 25081313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
    Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
    AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.
    Meade CS; Towe SL; Skalski LM; Robertson KR
    Drug Alcohol Depend; 2015 Apr; 149():128-35. PubMed ID: 25697913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.